Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Safflower Oil Might Be Beneficial Against Heart Disease

March 22, 2011 7:08 am | News | Comments

A daily dose of safflower oil, a common cooking oil, for 16 weeks can improve such health measures as good cholesterol, blood sugar, insulin sensitivity and inflammation in obese postmenopausal women who have Type 2 diabetes.


Stem Cell Transplant May Benefit Rapid MS Sufferers

March 22, 2011 7:04 am | News | Comments

A long term study reports about the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous stem cell rescue for people with aggressive forms of multiple sclerosis.


GROMIT Key Step in Studying Gene Regulation

March 22, 2011 6:48 am | News | Comments

Scientists have developed a new method for studying gene regulation. By employing a jumping gene as an informant, researchers can systematically explore the very large part of our genome that does not code for proteins.


Polypill Likely to Be Safe And Effective

March 22, 2011 6:44 am | News | Comments

For a patient at high risk of cardiovascular disease, keeping up with what pills to take at different times of the day can be tedious. Many people, especially the elderly, often forget doses or take the wrong pill at the wrong time.


New Software Designed to Minimize Synthetic Biology Risks

March 22, 2011 6:42 am | News | Comments

A software package designed to minimize the potential risks of synthetic biology for the nation's defense and security is now available to the gene synthesis industry and synthetic biology community in an open-source format.


ACE-ARB Combo Linked to Increased Risk

March 22, 2011 6:40 am | News | Comments

According to a new study, eElderly patients prescribed combination angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) had a higher risk of kidney failure and death.


MAb Characterization Platforms

March 21, 2011 8:33 am | Drug Discovery & Development | Product Releases | Comments

Dionex has released three MAbPac SCX-10 column formats for faster MAb analysis, pH gradients, and LC/MS use. The MAbPac SCX-10 is designed specifically for high-resolution analysis and characterization of MAb variants.


Flash Purification System

March 21, 2011 8:27 am | Product Releases | Comments

Agilent Technologies, Inc. introduced the Agilent 971-FP Flash Purification System, a personal flash chromatography instrument for pharmaceutical chemists, offering fast, easy, and secure purification of new synthetic compounds.


Ductless Fume Hoods

March 21, 2011 8:22 am | Product Releases | Comments

The PURAIR 5 Ductless Fume Hoods from Air Science USA feature a high level of operator protection where routine work is being carried out. The units exceed OSHA, ANSI and all relevant international standards.


Jacketed Reactor

March 21, 2011 8:20 am | Product Releases | Comments

Syrris will launch the Globe jacketed reactor platform at the Spring ACS Expo. This chemical reactor enables vessels from 50 mL to 5 L to use a common clamp, lid, circulator and stand.


AB SCIEX And Alturas Working on DBS Analysis

March 21, 2011 8:03 am | News | Comments

AB SCIEX and Alturas Analytics Inc., a provider of LC/MS contract research services, announced a collaboration to accelerate the adoption of dried blood spot analysis for drug discovery & development.


Quanta Collaborating with IDT on miRNA

March 21, 2011 7:55 am | News | Comments

Quanta Biosciences has developed hundreds of assays for quantifying microRNAs, and has entered into a partnership with Integrated DNA Technologies to custom manufacture them.


Prophylactic Antibiotics Lowers Risk in ICU

March 21, 2011 7:53 am | News | Comments

Giving critically ill patients antibiotics as a preventive measure significantly reduces the risk of infection with highly resistant microorganisms, according to the largest prospective study of topical preventive antibiotics in intensive care unit.


Organic Nanoparticle Uses Heat Against Tumors

March 21, 2011 7:50 am | News | Comments

A team of scientists have created an organic nanoparticle that is completely non-toxic, biodegradable and nimble in the way it uses light and heat to treat cancer and deliver drugs.


LNA Compounds Can Inhibit Disease Families

March 21, 2011 7:44 am | News | Comments

A new study demonstrates that Locked Nucleic Acid (LNA)-based compounds developed by Santaris Pharma A/S can inhibit entire disease-associated microRNA families. This provides a potential new approach for treating a variety of diseases.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.